论文部分内容阅读
Owing to its role in immunosuppression and immune escape,indoleamine 2,3-dioxygenase(IDO),a rate-limiting enzyme in the major pathway of L-tryptophan catabolism,has been regarded as an important target for the treatment of cancer [1].